The Utility of Structural Biology in Drug Discovery
- 7 December 2011
- book chapter
- Published by Springer Nature
- Vol. 841, 1-27
Abstract
Access to detailed three-dimensional structural information on protein drug targets can streamline many aspects of drug discovery, from target selection and target product profile determination, to the discovery of novel molecular scaffolds that form the basis of potential drugs, to lead optimization. The information content of X-ray crystal structures, as well as the utility of structural methods in supporting the different phases of the drug discovery process, are described in this chapter.Keywords
This publication has 30 references indexed in Scilit:
- Histone deacetylase inhibitors: Potential in cancer therapyJournal of Cellular Biochemistry, 2009
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition†Journal of Molecular Biology, 2001
- Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug DiscoveryJournal of Chemical Information and Computer Sciences, 2001
- Protein titration in the crystal stateJournal of Molecular Biology, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Returns to R&D on new drug introductions in the 1980sJournal of Health Economics, 1994
- Active-centre torsion-angle strain revealed in 1.6 Å-resolution structure of histidine-containing phosphocarrier proteinNature, 1993
- Free R value: a novel statistical quantity for assessing the accuracy of crystal structuresNature, 1992